Syndrome d'hypersensibilité aux antiépileptiques. Cas particulier de la lamotrigine = Anticonvulsant hypersensitivity syndrome and lamotrigine-associated anticonvulsant hypersensitivity syndromeTAILLIA, H; ALLA, P; FOURNIER, B et al.Revue neurologique (Paris). 2009, Vol 165, Num 10, pp 821-827, issn 0035-3787, 7 p.Article

Acute lamotrigine overdose in an adolescentREIMERS, Arne; REINHOLT, Guro.Therapeutic drug monitoring. 2007, Vol 29, Num 5, pp 669-670, issn 0163-4356, 2 p.Article

Treatment of inhalant dependence with lamotrigineSHEN, Yu-Chih.Progress in neuro-psychopharmacology & biological psychiatry. 2007, Vol 31, Num 3, pp 769-771, issn 0278-5846, 3 p.Article

Final results from 18 years of the International Lamotrigine Pregnancy RegistryCUNNINGTON, M. C; WEIL, J. G; MESSENHEIMER, J. A et al.Neurology. 2011, Vol 76, Num 21, pp 1817-1823, issn 0028-3878, 7 p.Article

Effect of antiepileptic drug comedication on lamotrigine clearanceWEINTRAUB, David; BUCHSBAUM, Richard; RESOR, Stanley R et al.Archives of neurology (Chicago). 2005, Vol 62, Num 9, pp 1432-1436, issn 0003-9942, 5 p.Article

Lamotrigine-induced rash : worth a rechallengeCODREA, S. P; SIDENIUS, P; DAM, M et al.Acta neurologica scandinavica. 2005, Vol 111, Num 3, pp 191-194, issn 0001-6314, 4 p.Article

Life-Threatening Organ Failure After Lamotrigine TherapyFERGUSON, Lee P; DARGAN, Paul I; HOOD, Joanne L et al.Pediatric neurology. 2009, Vol 40, Num 5, pp 392-394, issn 0887-8994, 3 p.Article

Pharma-clinics le médicament du mois: La lamotrigine (Lamictal®) = Lamotrigine:drug of the monthSCHEEN, A. J.RMLG. Revue médicale de Liège. 1997, Vol 52, Num 11, pp 738-740, issn 0370-629XArticle

A meta-analysis of individual patient responses to lamotrigine or carbamazepine monotherapyGAMBLE, C; WILLIAMSON, P. R; CHADWICK, D. W et al.Neurology. 2006, Vol 66, Num 9, pp 1310-1317, issn 0028-3878, 8 p.Article

The impact of pregnancy and childbirth on the metabolism of lamotriginePENNELL, P. B; NEWPORT, D. J; STOWE, Z. N et al.Neurology. 2004, Vol 62, Num 2, pp 292-295, issn 0028-3878, 4 p.Article

Lamotrigine-associated anticonvulsant hypersensitivity syndrome in bipolar disorderCHANG, Chuan-Chia; SHIAH, I.-Shin; YEH, Chin-Bin et al.Progress in neuro-psychopharmacology & biological psychiatry. 2006, Vol 30, Num 4, pp 741-744, issn 0278-5846, 4 p.Article

Valproic acid and lamotrigine treatment during pregnancy: The risk of chromosomal abnormalityOZKINAY, Ferda; COGULU, Ozgur; GUNDUZ, Cumhur et al.Mutation research. Genetic toxicology and environmental mutagenesis. 2003, Vol 534, Num 1-2, pp 197-199, issn 1383-5718, 3 p.Article

Late Adverse Effects of the Coadministration of Valproate and LamotrigineTHOME-SOUZA, Sigride; MOREIRA, Bernardo; VALENTE, Kette D et al.Pediatric neurology. 2012, Vol 47, Num 1, pp 47-50, issn 0887-8994, 4 p.Article

Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteersMEADOR, K. J; LORING, D. W; VAHLE, V. J et al.Neurology. 2005, Vol 64, Num 12, pp 2108-2114, issn 0028-3878, 7 p.Article

Lamotrigine-induced common variable immune deficiencySMITH, Julie; FERNANDO, Tus; MCGRATH, Nicole et al.Neurology. 2004, Vol 62, Num 5, pp 833-834, issn 0028-3878, 2 p.Article

Gestation-induced changes in lamotrigine pharmacokinetics: A monotherapy studyDE HAAN, G-J; EDELBROEK, P; SEGERS, J et al.Neurology. 2004, Vol 63, Num 3, pp 571-573, issn 0028-3878, 3 p.Article

Anxiolytic effects of lamotrigine and JZP-4 in the elevated plus maze and in the four plate conflict testFOREMAN, Mark M; HANANIA, Taleen; ELLER, Mark et al.European journal of pharmacology. 2009, Vol 602, Num 2-3, pp 316-320, issn 0014-2999, 5 p.Article

A Prospective Open-Label Trial of Lamotrigine Monotherapy in Children and Adolescents with Bipolar DisorderBIEDERMAN, Joseph; JOSHI, Gagan; MICK, Eric et al.CNS neuroscience & therapeutics (Print). 2010, Vol 16, Num 2, pp 91-102, issn 1755-5930, 12 p.Article

Neuroleptic Malignant Syndrome Induced by LamotrigineISHIOKA, Masamichi; YASUI-FURUKORI, Norio; HASHIMOTO, Kojiro et al.Clinical neuropharmacology. 2013, Vol 36, Num 4, pp 131-132, issn 0362-5664, 2 p.Article

The relevance of monitoring lamotrigine serum concentrations in chronic pain patientsDEVULDER, Jacques.Acta neurologica belgica. 2006, Vol 106, Num 1, pp 15-18, issn 0300-9009, 4 p.Article

Brachioradial pruritus : A peculiar neuropathic disorderCREVITS, L.Clinical neurology and neurosurgery. 2006, Vol 108, Num 8, pp 803-805, issn 0303-8467, 3 p.Article

Attenuation of the Effects of Corticosteroids on Declarative Memory with LamotrigineBROWN, E. Sherwood; WOLFSHOHL, Justin; SHAD, Mujeeb U et al.Neuropsychopharmacology (New York, NY). 2008, Vol 33, Num 10, pp 2376-2383, issn 0893-133X, 8 p.Article

Human safety of lamotrigineBETTS, T; GOODWIN, G; WITHERS, R. M et al.Epilepsia (Copenhagen). 1991, Vol 32, pp S17-S21, issn 0013-9580, SUP2Conference Paper

Overview of the clinical efficacy of lamotrigineRICHENS, A; YUEN, A. W. C.Epilepsia (Copenhagen). 1991, Vol 32, pp S13-S16, issn 0013-9580, SUP2Conference Paper

In vivo biopharmaceutical characterisation of a new formulation containing the antiepileptic drug lamotrigine in comparison to plain and dispersible/chewable lamotrigine tabletsWANGEMANN, Martina; RETZOW, Angelika; POHLMANN-EDEN, Bernd et al.Arzneimittel-Forschung. 2005, Vol 55, Num 6, pp 307-311, issn 0004-4172, 5 p.Article